【レポートの概要（一部）】
Chapter 1: Introduction
1.1. Report Description
1.2. Key Market Segments
1.2.1. List of Key Players Profiled In The Report
1.3. Research Methodology
1.3.1. Primary Research
1.3.2. Secondary Research
1.3.3. Analyst Tools And Models
Chapter 2: Executive Summary
2.1. Key Findings of The Study
2.2. Cxo Perspective
Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Top Player Positioning
3.2.1. Top Investment Pockets
3.3. Key Forces Shaping Antihypertensive Industry/Market
3.4. Market Dynamics
3.4.1. Drivers
3.4.1.1. Surge In Geriatric Population Worldwide
3.4.1.2. Surge In Healthcare Expenditure Worldwide
3.4.1.3. Rise In Prevalence of Hypertension Across The Globe
3.4.2. Restraint
3.4.2.1. Patent Expirations of Blockbuster Drugs
3.4.3. Opportunity
3.4.3.1. High Growth Potential In Developing Economies
3.4.4. Impact Analyses
Chapter 4: Antihypertensive Drugs Market, By Drug Class
4.1. Overview
4.1.1. Market Size And Forecast
4.2. Diuretics
4.2.1. Key Market Trends, Growth Factors, And Opportunities
4.2.2. Market Size And Forecast, By Region
4.2.3. Market Analysis By Country
4.3. Ace Inhibitors
4.3.1. Key Market Trends, Growth Factors, And Opportunities
4.3.2. Market Size And Forecast, By Region
4.3.3. Market Analysis By Country
4.4. Calcium Channel Blockers
4.4.1. Key Market Trends, Growth Factors, And Opportunities
4.4.2. Market Size And Forecast, By Region
4.4.3. Market Analysis By Country
4.5. Beta-Adrenergic Blockers
4.5.1. Key Market Trends, Growth Factors, And Opportunities
4.5.2. Market Size And Forecast, By Region
4.5.3. Market Analysis By Country
4.6. Vasodilators
4.6.1. Key Market Trends, Growth Factors, And Opportunities
4.6.2. Market Size And Forecast, By Region
4.6.3. Market Analysis By Country
4.7. Others
4.7.1. Key Market Trends, Growth Factors, And Opportunities
4.7.2. Market Size And Forecast, By Region
4.7.3. Market Analysis By Country
Chapter 5: Antihypertensive Drugs Market, By End User
5.1. Overview
5.1.1. Market Size And Forecast
5.2. Retail Pharmacy
5.2.1. Market Size And Forecast, By Region
5.2.2. Market Analysis By Country
5.3. Hospital Pharmacy
5.3.1. Market Size And Forecast, By Region
5.3.2. Market Analysis By Country
5.4. E-Commerce Websites & Online Drug Stores
5.4.1. Market Size And Forecast, By Region
5.4.2. Market Analysis By Country
Chapter 6: Antihypertensive Drugs Market, By Region
6.1. Overview
6.1.1. Market Size And Forecast
6.2. North America
6.2.1. Key Market Trends And Opportunities
6.2.2. Market Analysis, By Country
6.2.2.1. U.S.
6.2.2.1.1. U.S. Market Size And Forecast, By Drug Class
6.2.2.1.2. U.S. Market Size And Forecast, By Distribution Channel
6.2.2.2. Canada
6.2.2.2.1. Canada Market Size And Forecast, By Drug Class
6.2.2.2.2. Canada Market Size And Forecast, By Distribution Channel
6.2.2.3. Mexico
6.2.2.3.1. Mexico Market Size And Forecast, By Drug Class
6.2.2.3.2. Mexico Market Size And Forecast, By Distribution Channel
6.2.3. North America Market Size And Forecast, By Drug Class
6.2.4. North America Market Size And Forecast, By Distribution Channel
6.3. Europe
6.3.1. Key Market Trends And Opportunities
6.3.2. Market Analysis, By Country
6.3.2.1. Germany
6.3.2.1.1. Germany Market Size And Forecast, By Drug Class
6.3.2.1.2. Germany Market Size And Forecast, By Distribution Channel
6.3.2.2. France
6.3.2.2.1. France Market Size And Forecast, By Drug Class
6.3.2.2.2. France Market Size And Forecast, By Distribution Channel
6.3.2.3. Uk
6.3.2.3.1. Uk Market Size And Forecast, By Drug Class
6.3.2.3.2. Uk Market Size And Forecast, By Distribution Channel
6.3.2.4. Italy
6.3.2.4.1. Italy Market Size And Forecast, By Drug Class
6.3.2.4.2. Italy Market Size And Forecast, By Distribution Channel
6.3.2.5. Rest of Europe
6.3.2.5.1. Rest of Europe Market Size And Forecast, By Drug Class
6.3.2.5.2. Rest of Europe Market Size And Forecast, By Distribution Channel
6.3.3. Europe Market Size And Forecast, By Drug Class
6.3.4. Europe Market Size And Forecast, By Distribution Channel
6.4. Asia-Pacific
6.4.1. Key Market Trends And Opportunities
6.4.2. Market Analysis, By Country
6.4.2.1. Japan
6.4.2.1.1. Japan Market Size And Forecast, By Drug Class
6.4.2.1.2. Japan Market Size And Forecast, By Distribution Channel
6.4.2.2. China
6.4.2.2.1. China Market Size And Forecast, By Drug Class
6.4.2.2.2. China Market Size And Forecast, By Distribution Channel
6.4.2.3. India
6.4.2.3.1. India Market Size And Forecast, By Drug Class
6.4.2.3.2. India Market Size And Forecast, By Distribution Channel
6.4.2.4. Rest of Asia-Pacific
6.4.2.4.1. Rest of Asia-Pacific Market Size And Forecast, By Drug Class
6.4.2.4.2. Rest of Asia-Pacific Market Size And Forecast, By Distribution Channel
6.4.3. Asia-Pacific Market Size And Forecast, By Drug Class
6.4.4. Asia-Pacific Market Size And Forecast, By Distribution Channel
6.5. Lamea
6.5.1. Key Market Trends And Opportunities
6.5.2. Market Analysis, By Country
6.5.2.1. Brazil
6.5.2.1.1. Brazil Market Size And Forecast, By Drug Class
6.5.2.1.2. Brazil Market Size And Forecast, By Distribution Channel
6.5.2.2. South Africa
6.5.2.2.1. South Africa Market Size And Forecast, By Drug Class
6.5.2.2.2. South Africa Market Size And Forecast, By Distribution Channel
6.5.2.3. Saudi Arabia
6.5.2.3.1. Saudi Arabia Market Size And Forecast, By Drug Class
6.5.2.3.2. Saudi Arabia Market Size And Forecast, By Distribution Channel
6.5.2.4. Rest of Lamea
6.5.2.4.1. Rest of Lamea Market Size And Forecast, By Drug Class
6.5.2.4.2. Rest of Lamea Market Size And Forecast, By Distribution Channel
6.5.3. Lamea Market Size And Forecast, By Drug Class
6.5.4. Lamea Market Size And Forecast, By Distribution Channel
Chapter 7: Company Profiles
7.1. Astrazeneca Plc
7.1.1. Company Overview
7.1.2. Company Snapshot
7.1.3. Operating Business Segments
7.1.4. Product Portfolio
7.1.5. Business Performance
7.2. Boehringer Ingelheim International Gmbh
7.2.1. Company Overview
7.2.2. Company Snapshot
7.2.3. Operating Business Segments
7.2.4. Product Portfolio
7.2.5. Business Performance
7.3. Daiichi Sankyo Company, Limited
7.3.1. Company Overview
7.3.2. Operating Business Segments
7.3.3. Product Portfolio
7.3.4. Business Performance
7.3.5. Key Strategic Moves And Developments
7.4. Johnson & Johnson
7.4.1. Company Overview
7.4.2. Company Snapshot
7.4.3. Operating Business Segments
7.4.4. Product Portfolio
7.4.5. Business Performance
7.5. Lupin
7.5.1. Company Overview
7.5.2. Company Snapshot
7.5.3. Operating Business Segments
7.5.4. Product Portfolio
7.5.5. Business Performance
7.6. Novartis Ag.
7.6.1. Company Overview
7.6.2. Company Snapshot
7.6.3. Operating Business Segments
7.6.4. Product Portfolio
7.6.5. Business Performance
7.7. Merck & Co., Inc
7.7.1. Company Overview
7.7.2. Company Snapshot
7.7.3. Operating Business Segments
7.7.4. Product Portfolio
7.7.5. Business Performance
7.8. Pfizer Inc.
7.8.1. Company Overview
7.8.2. Company Snapshot
7.8.3. Operating Business Segments
7.8.4. Product Portfolio
7.8.5. Business Performance
7.9. Sun Pharmaceutical Industries Ltd. (Ranbaxy Laboratories)
7.9.1. Company Overview
7.9.2. Company Snapshot
7.9.3. Operating Business Segments
7.9.4. Product Portfolio
7.9.5. Business Performance
7.9.6. Key Strategic Moves And Developments
7.10. Sanofi
7.10.1. Company Overview
7.10.2. Operating Business Segments
7.10.3. Product Portfolio
7.10.4. Business Performance
【レポート販売概要】
■ タイトル：降圧薬の世界市場：治療クラス別（利尿薬、ACE阻害薬、カルシウムチャネル遮断薬、血管拡張薬、ベータアドレナリン遮断薬、その他）、流通経路別（小売薬局、病院薬局、Eコマース、その他）■ 英文：Antihypertensive Drugs Market by Therapeutic Class (Diuretics, ACE Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-adrenergic Blockers, and Others) and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-commerce, and Others Distribution Channel): Global Opportunity Analysis and Industry Forecast, 2019–2026
■ 発行日：2019年12月31日
■ 調査会社：Allied Market Research
■ 商品コード：AMR20FE071
■ 調査対象地域：グローバル
- 世界のリカバリーSaaS市場Global economy and computerized revolution impacts businesses, customer loyalty, financial growth and productivity. Traditional disaster recovery (DR) constitutes a substantial portion of annual expenses for IT managers across organizations. With a cloud based recovery system ‘pay as you go’ model, the financial impact of downtime can be minimized through replication. The recovery system can start …
- 光ファイバーサーキュレーターのグローバル市場2014The deployment of optical fiber in the metro/access, the continuing demand for upgrading networks to accommodate rapidly increasing bandwidth requirements, plus the need for additional monitoring and testing of the optical fiber networks will drive the steady consumption of fiber optic circulators. As terrestrial national backbone and undersea systems approaching Tb/s capacities, advanced fiber-op …
- 通信事業者による保険・アシスタンスの世界市場Global Mobile Operators: Strategies in Insurance and Assistance is a report and interactive PartnerBASE dataset that provides a detailed worldwide overview of the fast-growing involvement of mobile operator brands and groups in the fields of insurance and assistance. For 286 brands spread across 92 countries, it outlines their activity and strategic partnerships for the following insurance and ass …
- 自動倉庫システム（ASRS）の世界市場予測（～2022）The automated storage and retrieval system (ASRS) market is expected to grow from USD 5.19 Billion in 2015 to reach USD 8.43 Billion by 2022, at a CAGR of 7.1% between 2016 and 2022. The ASRS market is currently witnessing a growing demand from automotive and food & beverages industries as ASRS is highly recommended in these industries for storing and retrieving goods from the inventory on a real- …
- ASSPの世界市場2015-2019About ASSP An application-specific standard product (ASSP) is a semiconductor device used for a specific application by multiple units. It is a general purpose IC that implements a specific function and caters to a wide market and not just to one customer. Consumers prefer ASSPs as there is no need to design the required IC from scratch, making them cost-effective. They are used in communications, …
- Atacicept (Systemic Lupus Erythematosus and Lupus Nephritis)：市場予測と分析（～2022）Atacicept (Systemic Lupus Erythematosus and Lupus Nephritis) - Forecast and Market Analysis to 2022 Summary Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune disease that can affect any organ or tissue and is the prototypic autoimmune disease. While SLE can affect multiple major organ systems in the body, one of its most severe manifestations includes renal (kidney) involvem …
- 世界のサニタリーポンプ市場：サニタリー渦巻ポンプ、容積式ポンプ、特殊ポンプAbout Sanitary Pumps Sanitary pumps, also known as hygienic pumps, are used in a production line to initiate the flow of sensitive medium that is highly prone to contamination. Sanitary pumps find their application mainly in the Food and Beverage, and Pharmaceuticals and Personal Care industries, where the hygiene standards are provided at most importance. Sanitary pumps can be classified into cen …
- 可同調ダイオードレーザー分析計（TDLA）の世界市場：酸素分析計、アンモニア分析計、COX分析計、湿度分析計、CXHX分析計、HX分析計The tunable diode laser analyzer (TDLA) market is expected to reach USD 569.2 Million by 2022, at a CAGR of 10.1% during the forecast period. The major drivers for the TDLA market are the industrialization in the developing countries as well increasing adoption of TDLA by the industries over traditional analyzer, along with the ability of TDLA to provide return on investment (RoI) on installation. …
- 世界の万引き防止システム・タグ市場動向（2012-2016）TechNavio's analysts forecast the Global Electronic Article Surveillance Systems market to grow at a CAGR of 2.88 percent over the period 2012-2016. One of the key factors contributing to this market growth is the robust growth in the global retail market. The Global Electronic Article Surveillance Systems market has also been witnessing the emerging source tagging in the retail sector. However, t …
- インテリジェント・モーター・コントローラーの世界市場動向・予測（～2021）The intelligent motor controller market is projected to reach a size of USD 857.6 Million by 2021, at a CAGR of 5.48% from 2016 to 2021. The report segments the intelligent motor controller market on the basis of major end-user industries into oil & gas, water & wastewater, power generation, food & beverage, metals & mining, chemicals & petrochemicals, cement & aggregates, pharmaceuticals, and oth …
- インスリン送達機器の世界市場：インスリン注射器、インスリン・ポンプ、インスリン・ペン、インスリン・ジェット式注射器About Insulin The cost of syringes and insulin pens is low, which enables users to opt for them as first choice devices. High cost of insulin pumps and insulin jet injectors poses a challenge to the growth of the market. Insulin pumps and jet injectors also require special care and maintenance, which is an additional cost burden to patients. Technavio’s analysts forecast the global insulin deliver …
- 消費者用ネットワークアタッチトストレージ（NAS）の世界市場分析The global consumer NAS market is expected to reach USD 8.20 billion by 2025, according to a new report by Grand View Research, Inc. Globally growing demand for efficient data backup systems, speedy data transfer, and cost-effective storage systems are some of the key drivers for the consumer network attached storage market. Home segment is one of the largest segment in 2016 and is expected to mai …
- RN Holding：石油・ガスの開発・生産動向及びコスト分析- 2012RN Holding Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary RN Holding Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operational data, …
- Respiratory Diseases in Italy 2014: Market Outlook and Emerging OpportunitiesAbout This ReportThis new 281-page report from Venture Planning Group presents detailed analysis of the Italian Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. …
- Squamous Non-Small Cell Lung Cancer：グローバル臨床試験動向（2014年上半期）Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014" provides data on the Squamous Non-Small Cell Lung Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Squamous Non-Small Cell Lung Canc …
